ATOSSA THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
ATOSSA THERAPEUTICS, INC. (ATOS) reported Basic Shares Outstanding (Weighted Average) of 8.91 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 8.91M shares, a 3.32% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 8.62M shares, a 0.00% change year-over-year.
- ATOSSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was -353.07M shares.
- ATOSSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 129.17M shares, a 2.70% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 8.61M shares, a 2.63% increase from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 8.39M shares, a 93.35% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 126.08M shares, a 0.43% decline from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 126.62M shares, a 8.27% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 8.91M shares 10-Q · filed 2026-08-07 | 8.77M shares 10-Q · filed 2026-08-07 | -111.85M shares derived: average of 3 quarters · filed 2026-08-07 | -51.59M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | 8.62M shares 10-Q · filed 2026-05-08 | -172.22M shares derived: average of 2 quarters · filed 2026-05-08 | -71.76M shares derived: average of 3 quarters · filed 2026-05-08 | -51.66M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | -353.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -111.95M shares derived: average of 2 quarters · filed 2026-03-25 | -71.76M shares derived: average of 3 quarters · filed 2026-08-07 | 8.61M shares 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | 129.17M shares 10-Q · filed 2025-11-12 | 68.90M shares derived: average of 2 quarters · filed 2026-08-07 | 129.17M shares 10-Q · filed 2025-11-12 | -49.21M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | 8.62M shares 10-Q · filed 2026-08-07 | 129.17M shares 10-Q · filed 2025-08-12 | 8.62M shares 10-Q · filed 2026-08-07 | 129.17M shares 10-Q · filed 2025-08-12 | -108.67M shares derived: average of 3 quarters · filed 2026-08-07 | -50.06M shares derived: average of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | 8.62M shares 10-Q · filed 2026-05-08 | 129.17M shares 10-Q · filed 2025-05-13 | -167.32M shares derived: average of 2 quarters · filed 2026-05-08 | -69.62M shares derived: average of 3 quarters · filed 2026-05-08 | -20.78M shares derived: average of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -343.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -108.75M shares derived: average of 2 quarters · filed 2026-03-25 | -30.59M shares derived: average of 3 quarters · filed 2026-03-25 | 8.39M shares 10-K · filed 2026-03-25 | 125.86M shares 10-K · filed 2025-03-25 | |||
| 2024-09-30 | 125.77M shares 10-Q · filed 2025-11-12 | 125.75M shares derived: average of 2 quarters · filed 2025-11-12 | 125.61M shares 10-Q · filed 2025-11-12 | 125.53M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 125.73M shares 10-Q · filed 2025-08-12 | 125.53M shares 10-Q · filed 2025-08-12 | 125.45M shares derived: average of 3 quarters · filed 2025-08-12 | 125.54M shares derived: average of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | 125.32M shares 10-Q · filed 2025-05-13 | 125.31M shares derived: average of 2 quarters · filed 2025-05-13 | 125.47M shares derived: average of 3 quarters · filed 2025-05-13 | 125.76M shares derived: average of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | 125.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | 125.54M shares derived: average of 2 quarters · filed 2025-03-25 | 125.90M shares derived: average of 3 quarters · filed 2025-03-25 | 126.08M shares 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | 125.79M shares 10-Q · filed 2024-11-12 | 125.79M shares 10-Q · filed 2023-11-13 | 126.21M shares derived: average of 2 quarters · filed 2024-11-12 | 126.34M shares 10-Q · filed 2024-11-12 | 126.34M shares 10-Q · filed 2023-11-13 | 126.42M shares derived: average of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | 126.62M shares 10-Q · filed 2024-08-12 | 126.62M shares 10-Q · filed 2023-08-14 | 126.62M shares 10-Q · filed 2024-08-12 | 126.62M shares 10-Q · filed 2023-08-14 | 126.62M shares derived: average of 3 quarters · filed 2024-08-12 | 126.62M shares derived: average of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | 126.62M shares 10-Q · filed 2024-05-13 | 126.62M shares 10-Q · filed 2023-05-15 | 126.62M shares derived: average of 2 quarters · filed 2024-05-13 | 126.62M shares derived: average of 3 quarters · filed 2024-05-13 | 126.62M shares derived: average of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | 126.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 126.62M shares derived: average of 2 quarters · filed 2024-04-01 | 126.62M shares derived: average of 3 quarters · filed 2024-04-01 | 126.62M shares 10-K · filed 2024-04-01 | 126.62M shares 10-K · filed 2023-03-22 | |||
| 2022-09-30 | 126.62M shares 10-Q · filed 2023-11-13 | 126.62M shares derived: average of 2 quarters · filed 2023-11-13 | 126.62M shares 10-Q · filed 2023-11-13 | 126.65M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 126.62M shares 10-Q · filed 2023-08-14 | 126.62M shares 10-Q · filed 2023-08-14 | 126.66M shares derived: average of 3 quarters · filed 2023-08-14 | 126.63M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 126.62M shares 10-Q · filed 2023-05-15 | 126.68M shares derived: average of 2 quarters · filed 2023-05-15 | 126.63M shares derived: average of 3 quarters · filed 2023-05-15 | 125.37M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 126.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 126.63M shares derived: average of 2 quarters · filed 2023-03-22 | 124.95M shares derived: average of 3 quarters · filed 2023-03-22 | 116.95M shares 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | 126.54M shares 10-Q · filed 2022-11-07 | 124.06M shares derived: average of 2 quarters · filed 2022-11-07 | 113.69M shares 10-Q · filed 2022-11-07 | |||||
| 2021-06-30 | 121.57M shares 10-Q · filed 2022-08-08 | 107.16M shares 10-Q · filed 2022-08-08 | ||||||
| 2021-03-31 | 92.59M shares 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |